Related Experiment Video
Updated: May 20, 2026

Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
The case for intrauterine gene therapy
Citra N Mattar1, Simon N Waddington, Arijit Biswas
1Experimental Fetal Medicine Group, Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Intrauterine gene therapy offers a promising approach to correct genetic disorders before birth, potentially preventing irreversible damage. Research in animal models shows promise, with ongoing studies in primates to assess long-term safety and effectiveness.
Area of Science:
- Genetics
- Developmental Biology
- Gene Therapy
Background:
- Single-gene disorders can lead to severe perinatal complications.
- Early intervention is crucial to prevent irreversible fetal organ damage.
Purpose of the Study:
- To review candidate diseases for intrauterine gene therapy.
- To discuss the current evidence and potential clinical applications of fetal gene therapy.
Main Methods:
- Review of existing literature on intrauterine gene therapy.
- Discussion of proof-of-cure in animal models.
- Assessment of ongoing research in non-human primate models.
Main Results:
- Successful correction of genetic defects demonstrated in animal models.
- Potential for preventing irreversible organ damage and enabling wider biodistribution, including to the brain.
- Ongoing investigations into long-term efficacy, durability, and safety.
Conclusions:
- Intrauterine gene therapy holds significant promise for treating genetic disorders prenatally.
- Further research is needed to evaluate long-term outcomes and maternal safety.
- Clinical applications are being explored for various candidate diseases.
Related Concept Videos
Gene Therapy
Gene Therapy
Intrauterine Drug Delivery Systems
In-vitro Mutagenesis
CRISPR
Microorganisms in Medicine and Therapeutics

